RhumbLine Advisers’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $659K | Buy |
33,139
+785
| +2% | +$15.6K | ﹤0.01% | 2494 |
|
|
2025
Q1 | $547K | Sell |
32,354
-34,049
| -51% | -$575K | ﹤0.01% | 2517 |
|
|
2024
Q4 | $1.23M | Sell |
66,403
-395
| -0.6% | -$7.3K | ﹤0.01% | 2138 |
|
|
2024
Q3 | $1.45M | Sell |
66,798
-1,412
| -2% | -$30.7K | ﹤0.01% | 2069 |
|
|
2024
Q2 | $1.34M | Buy |
68,210
+637
| +0.9% | +$12.5K | ﹤0.01% | 2086 |
|
|
2024
Q1 | $1.47M | Buy |
67,573
+1,027
| +2% | +$22.3K | ﹤0.01% | 2062 |
|
|
2023
Q4 | $1.92M | Buy |
66,546
+657
| +1% | +$19K | ﹤0.01% | 1922 |
|
|
2023
Q3 | $1.76M | Buy |
65,889
+817
| +1% | +$21.8K | ﹤0.01% | 1916 |
|
|
2023
Q2 | $2.41M | Sell |
65,072
-811
| -1% | -$30K | ﹤0.01% | 1799 |
|
|
2023
Q1 | $2.06M | Buy |
65,883
+1,717
| +3% | +$53.6K | ﹤0.01% | 1793 |
|
|
2022
Q4 | $1.91M | Buy |
64,166
+1,873
| +3% | +$55.8K | ﹤0.01% | 1809 |
|
|
2022
Q3 | $2.38M | Buy |
62,293
+2,495
| +4% | +$95.1K | ﹤0.01% | 1661 |
|
|
2022
Q2 | $3.26M | Buy |
59,798
+4,627
| +8% | +$252K | ﹤0.01% | 1491 |
|
|
2022
Q1 | $3.44M | Buy |
55,171
+2,115
| +4% | +$132K | ﹤0.01% | 1545 |
|
|
2021
Q4 | $5.34M | Buy |
53,056
+293
| +0.6% | +$29.5K | 0.01% | 1320 |
|
|
2021
Q3 | $4.75M | Sell |
52,763
-4,583
| -8% | -$412K | 0.01% | 1390 |
|
|
2021
Q2 | $5.29M | Buy |
57,346
+13,288
| +30% | +$1.23M | 0.01% | 1399 |
|
|
2021
Q1 | $4.26M | Buy |
44,058
+8,966
| +26% | +$866K | 0.01% | 1498 |
|
|
2020
Q4 | $1.83M | Buy |
35,092
+8,085
| +30% | +$421K | ﹤0.01% | 1894 |
|
|
2020
Q3 | $1.08M | Buy |
+27,007
| New | +$1.08M | ﹤0.01% | 1964 |
|